RecruitingPhase III🇵🇱 PolandEN originalColorectal cancerMetastatic / advanced

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This study aims to address the unmet medical need of participants with metastatic colorectal cancer (mCRC) who have previously been treated with irinotecan, oxaliplatin, a fluoropyrimidine, and bevacizumab, by demonstrating an overall survival prolongation with precemtabart tocentecan (Precem-TcT) as single agent or Precem-TcT in combination with bevacizumab compared to trifluoride/tipiracil (FTD-TPI) plus bevacizumab.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Potwierdzona diagnoza zaawansowanego raka jelita grubego
  • •Pacjent wcześniej otrzymywał określone leki (irinotekan, oksaliplatynę, fluoropirymidinę) i choroba się pogorszyła lub nie tolerował leczenia
  • •Maksymalnie 2 poprzednie linie leczenia w przypadku zaawansowanego nowotworu
  • •Dobry ogólny stan zdrowia (skala ECOG 0 lub 1)
  • •Zdolność połykania tabletek doustnych

✗ Disqualifies

  • •Niepowstrzymane efekty uboczne z wcześniejszych terapii
  • •Historia innego nowotworu w ciągu ostatnich 3 lat
  • •Przerzuty do mózgu
  • •Perforacja lub przesączenie przewodu pokarmowego w ciągu ostatnich 6 miesięcy
  • •Niedrożność jelit, niezowiniętość jelit lub zapalenie jelit (wrzodziejące zapalenie jelita grubego, choroba Crohna)

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
October 8, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (92)

Rocky Mountain Cancer Centers, LLP- Aurora

Lone Tree, United States

Florida Cancer Specialists-Broadway

Fort Myers, United States

Florida Cancer Specialists - St. Petersburg Bayfront

St. Petersburg, United States

Florida Cancer Specialists East - FCS EAST - West Palm Beach

West Palm Beach, United States

Illinois Cancer Specialists

Arlington Heights, United States

Illinois CancerCare PC

Peoria, United States

Springfield Clinic

Springfield, United States

Profound Research LLC at Cancer and Leukemia Center

Sterling Heights, United States

Minnesota Oncology Hematology, P.A.

Saint Louis Park, United States

Missouri Cancer Associates - 150518964

Columbia, United States

White Plains Hospital Medical and Wellness PRIME

White Plains, United States

SCRI Oncology Partners

Nashville, United States

Texas Oncology, P.A. - Abilene - 300210366

Abilene, United States

Texas Oncology-South Austin

Austin, United States

Texas Oncology DFW

Bedford, United States

Texas Oncology- San Antonio

San Antonio, United States

Texas Oncology, P.A. - Tyler

Tyler, United States

Virginia Oncology Associates

Newport News, United States

Blue Ridge Cancer Care - 300202915

Roanoke, United States

Instituto de Oncologia de Rosario

Rosario, Argentina

Investigaciones Clinicas Moleculares ICM

Ciudad Autonoma Buenos Aires, Argentina

Centro Oncologico de Excelencia

San Juan, Argentina

Centro de Investigaciones Medicas Tucuman

San Miguel de Tucumán, Argentina

GenesisCare North Shore (Oncology)

St Leonards, Australia

Icon Cancer Centre Chermside

Chermside, Australia

Mater Misericordiae Ltd - PARENT

South Brisbane, Australia

Flinders Medical Centre

Bedford Park, Australia

LKH - Universitätsklinikum der PMU Salzburg - Innere Med III/Hämatologie und Onkologie

Salzburg, Austria

Cliniques Universitaires Saint-Luc - STL

Brussels, Belgium

Grand Hospital de Charleroi - PARENT

Charleroi, Belgium

UZA - Account 3

Edegem, Belgium

UZ Leuven

Leuven, Belgium

The Ottawa Hospital Cancer Centre

Ottawa, Canada

University Health Network - Princess Margaret Cancer Centre

Toronto, Canada

Peking Union Medical College Hospital

Beijing, China

Sun Yat-sen University Cancer Center

Guangzhou, China

Guangxi Medical University Cancer Hospital

Nanning, China

The University of Hong Kong - 1

Hong Kong, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, China

Jiangsu Province Hospital

Nanjing, China

Fudan University Shanghai Cancer Center

Shanghai, China

Sichuan Cancer Hospital

Chengdu, China

The Second Affiliated Hospital of Zhejiang University School of Medicine - 300173725

Hangzhou, China

Institut Bergonié - Service d'Oncologie Médicale

Bordeaux, France

Hopital Claude Huriez - CHU Lille - service d'oncologie medicale

Lille, France

CHU Saint Etienne - Hôpital Nord - Service de Gastro-Entérologie et Hépatologie

Saint Priest En Jarez, France

Centre Leon Berard - Service d'Oncologie Medicale

Lyon, France

Institut Gustave Roussy - Pathologies Digestives

Villejuif, France

Groupe Hospitalier Pitie-Salpetriere - Service Hépato-Gastro-Entérologie

Paris, France

Krankenhaus Nordwest GmbH - Neurologische Klinik

Frankfurt am Main, Germany

Universitaetsklinikum Leipzig AoeR - Universitaeres Krebszentrum Leipzig (UCCL)

Leipzig, Germany

Haematologisch-Onkologische Praxis Eppendorf (HOPE)

Hamburg, Germany

The Chinese University of Hong Kong (CUHK) - Prince of Wales Hospital (PWH)

Hong Kong, Hong Kong

IEO Istituto Europeo di Oncologia - Divisione Oncologia Medica

San Giovanni Rotondo, Italy

Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli" - Dipartimento di Oncologia

Naples, Italy

Istituto Nazionale Tumori Fondazione G. Pascale - Dipartimento Oncoematologia

Naples, Italy

Azienda Ospedaliero Universitaria Pisana - U.O. Oncologia II

Pisa, Italy

Aichi Cancer Center Hospital

Nagoya, Japan

NHO Kyushu Cancer Center - 300175822

Fukuoka, Japan

Kanagawa Cancer Center - Dept of Gastroenterology

Yokohama, Japan

Kindai University Hospital

Sakai-shi, Japan

Saitama Cancer Center - 300175812

Kitaadachi-gun, Japan

National Cancer Center Hospital

Chūōku, Japan

Cancer Institute Hospital of JFCR

Kōtoku, Japan

Osaka International Cancer Institute

Osaka, Japan

Amphia Ziekenhuis, Molengracht - Parent

Utrecht, Netherlands

Wojewodzkie Centrum Onkologii

Gdansk, Poland

SP ZOZ Szpital Uniwersytecki w Krakowie - Dept of Clinical Oncology and Oncology Clinic

Krakow, Poland

National Cancer Center

Goyang-si, South Korea

Seoul National University Bundang Hospital

Seongnam-si, South Korea

Kyungpook National University Chilgok Hospital

Daegu, South Korea

Seoul National University Hospital

Seoul, South Korea

Severance Hospital, Yonsei University Health System - Division of Infectious Diseases

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

The Catholic University of Korea, Seoul St. Maryâ

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Hospital Universitario Reina Sofia - Dept of Oncology

Córdoba, Spain

Hospital Universitari Vall d'Hebron - Oncology Dept.

Barcelona, Spain

Hospital Clinic de Barcelona - Servicio de Oncologia

Barcelona, Spain

Hospital Universitario Ramon y Cajal - Servicio de Oncologia

Madrid, Spain

Hospital Universitario Nuestra Señora de Valme

Seville, Spain

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, Taiwan

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan

China Medical University Hospital

Taichung, Taiwan

National Cheng Kung University Hospital - Internal Medicine

Tainan, Taiwan

Chi Mei Hospital, Liouying

Tainan, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

Taipei Veterans General Hospital

Taipei, Taiwan

Aberdeen Royal Infirmary - Dept of Oncology

Aberdeen, United Kingdom

The Christie Hospital - Dept of Oncology

Manchester, United Kingdom

Sarah Cannon Research Institute UK

London, United Kingdom

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.